Published in Magn Reson Med on June 01, 2006
Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T. Magn Reson Med (2008) 1.13
The role of gray and white matter segmentation in quantitative proton MR spectroscopic imaging. NMR Biomed (2012) 1.02
Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis. Radiology (2010) 0.86
Anteroposterior hippocampal metabolic heterogeneity: three-dimensional multivoxel proton 1H MR spectroscopic imaging--initial findings. Radiology (2008) 0.82
Multivoxel proton MR spectroscopy used to distinguish anterior cingulate metabolic abnormalities in patients with schizophrenia. Radiology (2011) 0.81
Voxel-shift and interpolation for hadamard-encoded MR images. Magn Reson Med (2008) 0.79
Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.79
Brain metabolites B1-corrected proton T1 mapping in the rhesus macaque at 3 T. Magn Reson Med (2010) 0.79
Three-dimensional Hadamard-encoded proton spectroscopic imaging in the human brain using time-cascaded pulses at 3 Tesla. Magn Reson Med (2013) 0.76
MRSI via fully-refocused spatiotemporal encoding with polychromatic spectral pulses. J Magn Reson (2015) 0.75
Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T. AJNR Am J Neuroradiol (2016) 0.75
Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging. Hum Brain Mapp (2017) 0.75
Diffuse axonal injury in mild traumatic brain injury: a diffusion tensor imaging study. J Neurosurg (2005) 2.78
Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson (2011) 2.30
Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2013) 2.29
T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson (2012) 1.88
T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology (2012) 1.83
Cardiac magnetic resonance T1 mapping of left atrial myocardium. Heart Rhythm (2013) 1.73
Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS. Neurology (2012) 1.62
Left ventricular global function index by magnetic resonance imaging--a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension (2013) 1.61
Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences. J Magn Reson Imaging (2011) 1.59
Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy. AJNR Am J Neuroradiol (2005) 1.56
T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson (2012) 1.55
Zwilch, a new component of the ZW10/ROD complex required for kinetochore functions. Mol Biol Cell (2003) 1.48
Optimizing the efficiency of high-field multivoxel spectroscopic imaging by multiplexing in space and time. Magn Reson Med (2006) 1.35
The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.32
Human brain-structure resolved T(2) relaxation times of proton metabolites at 3 Tesla. Magn Reson Med (2007) 1.28
Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology (2012) 1.27
Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med (2003) 1.22
Comparison of the effectiveness of saturation pulses in the heart at 3T. Magn Reson Med (2008) 1.22
Optimizing the precision-per-unit-time of quantitative MR metrics: examples for T1, T2, and DTI. Magn Reson Med (2007) 1.22
Human hippocampal subfields in young adults at 7.0 T: feasibility of imaging. Radiology (2010) 1.20
Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med (2002) 1.16
Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T. Magn Reson Med (2008) 1.13
Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage (2004) 1.12
Chemical-shift artifact reduction in Hadamard-encoded MR spectroscopic imaging at high (3T and 7T) magnetic fields. Magn Reson Med (2007) 1.10
Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners. J Cardiovasc Magn Reson (2013) 1.04
On the voxel size and magnetic field strength dependence of spectral resolution in magnetic resonance spectroscopy. Magn Reson Imaging (2008) 1.02
Robust fully automated shimming of the human brain for high-field 1H spectroscopic imaging. Magn Reson Med (2006) 1.02
The role of gray and white matter segmentation in quantitative proton MR spectroscopic imaging. NMR Biomed (2012) 1.02
A framework of whole heart extracellular volume fraction estimation for low-dose cardiac CT images. IEEE Trans Inf Technol Biomed (2012) 1.02
Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T. MAGMA (2008) 1.02
Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am J Psychiatry (2007) 1.01
Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study. J Neurol (2012) 1.00
The optimal MR acquisition strategy for exponential decay constants estimation. Magn Reson Imaging (2008) 1.00
Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group. J Magn Reson Imaging (2005) 0.99
Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA). Circulation (2012) 0.98
The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.98
Longitudinal inter- and intra-individual human brain metabolic quantification over 3 years with proton MR spectroscopy at 3 T. Magn Reson Med (2011) 0.97
Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging (2003) 0.96
Global average gray and white matter N-acetylaspartate concentration in the human brain. Neuroimage (2008) 0.94
Whole brain N-acetylaspartate concentration is conserved throughout normal aging. Neurobiol Aging (2012) 0.93
3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium. Int J Cardiovasc Imaging (2013) 0.92
Dilated perivascular spaces: hallmarks of mild traumatic brain injury. AJNR Am J Neuroradiol (2005) 0.92
Proton MR spectroscopy correlates diffuse axonal abnormalities with post-concussive symptoms in mild traumatic brain injury. J Neurotrauma (2013) 0.91
Partition coefficients for gadolinium chelates in the normal myocardium: comparison of gadopentetate dimeglumine and gadobenate dimeglumine. J Magn Reson Imaging (2012) 0.90
Characterizing 'mild' in traumatic brain injury with proton MR spectroscopy in the thalamus: Initial findings. Brain Inj (2007) 0.89
Whole-brain N-acetylaspartate level and cognitive performance in HIV infection. AJNR Am J Neuroradiol (2003) 0.89
Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. Radiology (2004) 0.88
Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol (2002) 0.87
Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis. Radiology (2010) 0.86
In vivo 7 Tesla imaging of the dentate granule cell layer in schizophrenia. Schizophr Res (2013) 0.86
C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions. Clin Nucl Med (2008) 0.84
Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis. Curr Opin Cardiol (2013) 0.84
TriTone: a radiofrequency field (B1)-insensitive T1 estimator for MRI at high magnetic fields. Magn Reson Imaging (2008) 0.83
Regional metabolite T2 in the healthy rhesus macaque brain at 7T. Magn Reson Med (2008) 0.83
Localization errors in MR spectroscopic imaging due to the drift of the main magnetic field and their correction. Magn Reson Med (2012) 0.82
Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients. Epilepsy Behav (2013) 0.82
3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis. J Cardiovasc Comput Tomogr (2012) 0.82
Anteroposterior hippocampal metabolic heterogeneity: three-dimensional multivoxel proton 1H MR spectroscopic imaging--initial findings. Radiology (2008) 0.82
Differentiating shunt-responsive normal pressure hydrocephalus from Alzheimer disease and normal aging: pilot study using automated MRI brain tissue segmentation. J Neurol (2014) 0.81
MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. AJNR Am J Neuroradiol (2005) 0.81
Multivoxel proton MR spectroscopy used to distinguish anterior cingulate metabolic abnormalities in patients with schizophrenia. Radiology (2011) 0.81
Pairwise protein structure alignment based on an orientation-independent backbone representation. J Bioinform Comput Biol (2004) 0.81
Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury. Neurology (2014) 0.81
Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol (2003) 0.80
Metabolite proton T(2) mapping in the healthy rhesus macaque brain at 3 T. Magn Reson Med (2009) 0.79
Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.79
Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration. Eur J Radiol (2013) 0.79
Brain metabolites B1-corrected proton T1 mapping in the rhesus macaque at 3 T. Magn Reson Med (2010) 0.79
Voxel-shift and interpolation for hadamard-encoded MR images. Magn Reson Med (2008) 0.79
Point-guided modeling and segmentation of myocardium for low dose cardiac CT images. Conf Proc IEEE Eng Med Biol Soc (2012) 0.79
Clinical significance of dilated Virchow-Robin spaces in mild traumatic brain injury. Brain Inj (2006) 0.79
Automated whole-brain N-acetylaspartate proton MRS quantification. NMR Biomed (2014) 0.79
Influences of human and livestock density on winter habitat selection of Mongolian gazelle (Procapra gutturosa). Zoolog Sci (2014) 0.79
The whole-brain N-acetylaspartate correlates with education in normal adults. Psychiatry Res (2012) 0.78
Brain compression without global neuronal loss in meningiomas: whole-brain proton MR spectroscopy report of 2 cases. AJNR Am J Neuroradiol (2005) 0.78
Proton MR spectroscopic imaging of rhesus macaque brain in vivo at 7T. Magn Reson Med (2008) 0.78
Anticancer activity of chamaejasmine: effect on tubulin protein. Molecules (2011) 0.77
Non-spin-echo 3D transverse hadamard encoded proton spectroscopic imaging in the human brain. Magn Reson Med (2012) 0.77
In vivo free induction decay based 3D multivoxel longitudinal hadamard spectroscopic imaging in the human brain at 3 T. Magn Reson Med (2012) 0.77
Retrospective correction for T1-weighting bias in T2 values obtained with various spectroscopic spin-echo acquisition schemes. Magn Reson Imaging (2009) 0.77
Cross-sectional and longitudinal reproducibility of rhesus macaque brain metabolites: a proton MR spectroscopy study at 3 T. Magn Reson Med (2011) 0.76
Structure-specific glial response in a macaque model of neuroAIDS: multivoxel proton magnetic resonance spectroscopic imaging at 3 Tesla. AIDS (2013) 0.76
Global gray and white matter metabolic changes after simian immunodeficiency virus infection in CD8-depleted rhesus macaques: proton MRS imaging at 3 T. NMR Biomed (2013) 0.76
Three-dimensional Hadamard-encoded proton spectroscopic imaging in the human brain using time-cascaded pulses at 3 Tesla. Magn Reson Med (2013) 0.76